A Clinical Oncology Pharmacist Has Your Back: discover their superpowers in this episode

A clinical oncology pharmacist has your back! 

They can help ensure you understand your treatment and how to manage its side effects.

They are experts in how your treatment interacts with other medications and supplements you take.

In this episode of Everything Cancer, we dive into the pivotal role of a clinical oncology pharmacist with our guest, Mark Wagner. Through Mark's insights, we gain a sense of the people-oriented nature of the Clinical Oncology Pharmacist role. 

Key Takeaways:

• Understanding the Role: Mark sheds light on why your Clinical Oncology Pharmacist is worth your time and attention.
• Supplement Safety: Insight into how supplements can interact with cancer treatments and the importance of informing your healthcare team about any non-prescribed substances you are taking.
• Immunotherapy Insights: Learn about the potential side effects of immunotherapy, how they are managed, and the importance of patient education in ensuring safe and effective treatment.
• Future of Oncology: Discover advancements in BITE therapy, making cutting-edge treatments more accessible in community settings.
• Michigan’s POEM Initiative: Mark’s investment in exceptional patient care is evident through his involvement in the POEM initiative. He invites Michigan Oncology Pharmacists to join.
• Survivorship Clinic Plans: The need for expert survivorship care is apparent. Mark shares his collaboration with oncology care experts and the initiative to launch a Survivorship Clinic staffed by a Clinical Oncology Pharmacist and an Advanced Practice provider.
• Empowering Patients: The importance of communication and education in empowering patients to take an active role in their treatment and care.

Guest Bio:

Mark Wagner, PharmD, BCOP, is a dedicated clinical oncology pharmacist based in Michigan. With a passion for patient care and education, Mark plays a crucial role in optimizing treatment plans, managing side effects, and ensuring patients have the information they need to

Slower